脑部放疗，上午比下午敏感许多！4 W8 d, x9 E+ _+ F; u7 ^# ?6 p6 f
+ {# {0 k/ d8 `( t: h+ c& z
$ A% |! u' k! E: gCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
' N" {# P9 H$ w- L. kGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
) g! _& i ]* U( VRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
4 P8 c5 E, d( g% A7 M7 U) y- \SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.& s+ j7 J6 L* ^6 p% B8 l
* W3 P; R3 H5 @% n: UAbstract
3 g9 X0 d: Q# W2 [0 L8 m7 C7 B% fBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
! t5 [' E9 V1 W& u D, n# H1 X0 K4 n, l$ r
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
. g+ x- e/ R) P* n* N5 X
% C( C5 e* j( x7 B2 ^( E0 g* ^RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)./ O. @- D0 m* @# N) F0 S: W
5 F& @5 W( _3 M @: @9 J: j; ~. t( Z
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
* n4 Y2 I1 }2 B7 X% \8 g
* Z- p6 y$ C; {8 V, `) h |
显身卡
